SOA Wealth Advisors’s Aspire Biopharma ASBP Stock Holding History

SOA Wealth Advisors’s Portfolio ASBP Stock Details ASBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$602	–	917
2025 Q3	$602	Buy	+2	New	+$1K	﹤0.01%	792

Other funds holding ASBP

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Crewe Advisors Salt Lake City, Utah $1.38B AUM 41.76% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAS

Optivise Advisory Services Franklin, Tennessee $197M AUM 26.07% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Procyon Advisors Shelton, Connecticut $2.32B AUM 26.81% 1-Year Est. Return

Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return

Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return

SOA Wealth Advisors's ASBP Position: Q4 2025 in Review

SOA Wealth Advisors sold out of Aspire Biopharma (ASBP) in Q4 2025, closing a stake of 2 shares — an estimated $602 sold.

SOA Wealth Advisors first reported a position in ASBP in Q3 2025 and held it in 1 quarter. The position peaked at $602 in Q3 2025. 28 funds tracked by Wall St. Rank hold ASBP as of Q4 2025.

SOA Wealth Advisors reported no remaining Aspire Biopharma position as of Q4 2025 after selling out during the quarter.
SOA Wealth Advisors sold 2 Aspire Biopharma shares in Q4 2025, an estimated $602.
SOA Wealth Advisors first reported a position in Aspire Biopharma in Q3 2025 and held it in 1 quarter.
SOA Wealth Advisors's Aspire Biopharma position peaked at $602 in Q3 2025.
28 funds tracked by Wall St. Rank held Aspire Biopharma as of Q4 2025.

Based on SOA Wealth Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.